Winton Group’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,509
Closed -$390K 1498
2021
Q3
$390K Sell
6,509
-4,745
-42% -$293K 0.02% 983
2021
Q2
$763K Sell
11,254
-869
-7% -$59.3K 0.04% 675
2021
Q1
$795K Buy
12,123
+680
+6% +$40.8K 0.05% 601
2020
Q4
$645K Sell
11,443
-12,755
-53% -$627K 0.05% 656
2020
Q3
$1.18M Sell
24,198
-4,656
-16% -$251K 0.04% 752
2020
Q2
$1.61M Sell
28,854
-21,922
-43% -$1.27M 0.04% 754
2020
Q1
$2.57M Buy
50,776
+32,161
+173% +$2.16M 0.07% 485
2019
Q4
$1.44M Sell
18,615
-2,707
-13% -$191K 0.02% 920
2019
Q3
$1.35M Buy
+21,322
New +$1.33M 0.02% 710

Other funds holding NUVA

Winton Group's NUVA Position: Q4 2021 in Review

Winton Group sold out of NuVasive, Inc. (NUVA) in Q4 2021, closing a stake of 6,509 shares — an estimated $390K sold.

Winton Group first reported a position in NUVA in Q3 2019 and held it in 9 quarters. The position peaked at $2.57M in Q1 2020. 249 funds tracked by Wall St. Rank hold NUVA as of Q4 2021.

  • Winton Group reported no remaining NuVasive, Inc. position as of Q4 2021 after selling out during the quarter.
  • Winton Group sold 6,509 NuVasive, Inc. shares in Q4 2021, an estimated $390K.
  • Winton Group first reported a position in NuVasive, Inc. in Q3 2019 and held it in 9 quarters.
  • Winton Group's NuVasive, Inc. position peaked at $2.57M in Q1 2020.
  • 249 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2021.

Based on Winton Group's 13F filing for Q4 2021, filed 10 Feb 2022.